Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SREBP-2 inhibitors(Sterol regulatory element-binding protein 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic dysfunction-associated steatotic liver disease | Preclinical | CN | 01 Sep 2023 |